![Wolfgang Baiker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wolfgang Baiker
Directeur/Membre du Conseil chez
PhotonPharma, Inc.
Profil
Wolfgang Baiker is currently a Director at Boehringer Ingelheim RCV GmbH & Co. KG and PhotonPharma, Inc. He is also a Venture Partner at Wellington Partners GmbH since 2016.
Previously, he served as the President & Chief Executive Officer at Boehringer Ingelheim Pharmaceuticals, Inc. from 2018 to 2020.
He was also the Chief Executive Officer at AdrenoMed AG in 2021 and 2022.
Prior to that, he worked as the Director-Operation & Biopharmaceuticals at Boehringer Ingelheim GmbH from 2013 to 2016.
Dr. Baiker holds an MBA from Pace University, a doctorate from the University of Louisiana at Monroe, an undergraduate degree from Ruhr-Universität Bochum, and another doctorate from Universität Ulm.
Postes actifs de Wolfgang Baiker
| Sociétés | Poste | Début |
|---|---|---|
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Germany, Europe and beyond. The firm focuses on life sciences companies. It provides financing for early and growth stage capital requirements with an investments size of EUR 2 - 20 million. It also acts as a lead and co-lead investor. | Private Equity Investor | 01/01/2016 |
Boehringer Ingelheim RCV GmbH & Co. KG
 Boehringer Ingelheim RCV GmbH & Co. KG BiotechnologyHealth Technology Develops and supplies biotherapeutic proteins, plasmid DNA and antibody fragments | Directeur/Membre du Conseil | - |
PhotonPharma, Inc.
 PhotonPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as an autologous therapy company for solid tumor cancers | Directeur/Membre du Conseil | - |
Anciens postes connus de Wolfgang Baiker
| Sociétés | Poste | Fin |
|---|---|---|
AdrenoMed AG
 AdrenoMed AG Pharmaceuticals: MajorHealth Technology Develops a drug to decrease mortality in severe sepsis | Directeur Général | 15/03/2022 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Directeur Général | 31/07/2020 |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Directeur des opérations | 04/08/2016 |
Formation de Wolfgang Baiker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Health Technology |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Germany, Europe and beyond. The firm focuses on life sciences companies. It provides financing for early and growth stage capital requirements with an investments size of EUR 2 - 20 million. It also acts as a lead and co-lead investor. | Finance |
Pace University
 Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Louisiana at Monroe
 University of Louisiana at Monroe Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ruhr-Universität Bochum
 Ruhr-Universität Bochum Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Universität Ulm
 Universität Ulm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim RCV GmbH & Co. KG
Boehringer Ingelheim RCV GmbH & Co. KG BiotechnologyHealth Technology Develops and supplies biotherapeutic proteins, plasmid DNA and antibody fragments | Health Technology |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology Develops a drug to decrease mortality in severe sepsis | Health Technology |
PhotonPharma, Inc.
PhotonPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as an autologous therapy company for solid tumor cancers | Health Technology |
